Pharma-Bio Serv (OTCMKTS:PBSV) Trading Up 2.7% – Time to Buy?

Pharma-Bio Serv Inc. (OTCMKTS:PBSV) shot up 2.7% during mid-day trading on Monday . The company traded as high as $0.58 and last traded at $0.58. Approximately 2,500 shares were traded during mid-day trading, an increase of 1,201% from the average daily volume of 192 shares. The stock had previously closed at $0.5650.

Pharma-Bio Serv Price Performance

The firm’s fifty day simple moving average is $0.56 and its 200 day simple moving average is $0.54.

Pharma-Bio Serv (OTCMKTS:PBSV) last issued its quarterly earnings results on Monday, June 15th. The company reported $0.01 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.03 by ($0.02). The company had revenue of $2.70 billion for the quarter, compared to analyst estimates of $2.70 million. Pharma-Bio Serv had a return on equity of 0.56% and a net margin of 0.68%. Sell-side analysts predict that Pharma-Bio Serv Inc. will post 0.07 EPS for the current year.

About Pharma-Bio Serv

Pharma-Bio Serv, Inc operates as a compliance and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company provides technical compliance consulting services comprising regulatory compliance, validation, technology transfer, engineering, project management, and process support for the pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies. Pharma-Bio Serv, Inc was founded in 1993 and is headquartered in Dorado, Puerto Rico.